CardioDiagnostics

Executive Summary

CardioDiagnostics, operating under the brand CardioOne Connect, is a US-based healthcare technology company that provides an integrated care management and remote monitoring platform for cardiology practices. Founded in 2015 and headquartered in Chicago, the company aims to extend care beyond traditional office visits by easing administrative burden, strengthening clinical outcomes, and simplifying practice operations. Its platform enables proactive, continuous cardiac care through technology and outsourced services, positioning it as a key player in the growing digital health and remote patient monitoring market. With a focus on cardiology—a high-acuity, high-cost specialty—CardioDiagnostics addresses critical pain points for providers, including reimbursement challenges and care coordination. The company's private status and lack of disclosed funding suggest it may be bootstrapped or in early growth stages, but its integrated approach and niche focus offer competitive differentiation against larger players like Livongo or BioTelemetry.

Upcoming Catalysts (preview)

• Q2 2026Series A or B Funding Round70% success
• Q4 2026Strategic Partnership with a Major Health System50% success
• Q3 2026Launch of AI-Enhanced Predictive Analytics Module60% success